(Q77714432)

English

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study

scientific article published on 01 December 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

P N Hopkins

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S C Hunt

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P J Schreiner

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J H Eckfeldt

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

I B Borecki

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C R Ellison

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R R Williams

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K D Siegmund

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

141

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

333-345

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum lipoprotein(a) and coronary artery disease in uremic patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Evaluation of lipoprotein (a) [Lp (a)] as a risk factor for coronary artery disease in the Turkish population

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) as a determinant of coronary heart disease in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Determinants of severity of coronary artery disease in Australian men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

NHLBI Family Heart Study: objectives and design

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A comparison of positive family history definitions for defining risk of future disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) and acute-phase proteins in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Transient changes of serum lipoprotein(a) as an acute phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Nutrient intake and progression of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein (a) and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a), fibrin binding, and plasminogen activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(98)00174-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77714432&oldid=1946525195"